19971203
 Health Brief -- IMCLONE SYSTEMS INC.: German Drug Firm Agrees To Vaccine Marketing Pact   The Wall Street Journal,  Dec 4, 1997  ImClone Systems Inc sait it expects to announce on Dec 4, 1997 that it has extended a vaccine co-marketing agreement with Merck KGaA under which the German drug maker will buy $40 million of ImClone preferred stock, make as much as $15 million in incentive payments and pay as much as $10 million to cover the cost of clinical trials.   
